Evidence map›Paper›PMID 33919949›Full record

ArticleBiomolecules2021

EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus.

Anna Obermayer, Norbert J Tripolt, Faisal Aziz, Christoph Högenauer, Felix Aberer, Florian Schreiber, Andreas Eherer, Caren Sourij, Vanessa Stadlbauer, Eva Svehlikova and 6 more

Open access · goldAbstract readClinical Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Endoscopic bariatrics: Current status and emerging technologies.World journal of gastrointestinal endoscopy · 2025
    Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Anna ObermayerDivision of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-7663-0426
Norbert J TripoltDivision of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.
Faisal AzizDivision of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-0109-2969
Christoph HögenauerDivision of Gastroenterology and Hepatology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-4566-0806
Felix AbererDivision of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-9947-1413
Florian SchreiberDivision of Gastroenterology and Hepatology, Medical University of Graz, 8010 Graz, Austria.
Andreas EhererDivision of Gastroenterology and Hepatology, Medical University of Graz, 8010 Graz, Austria.
Caren SourijDepartment of Internal Medicine, Division of Cardiology, Medical University of Graz, 8010 Graz, Austria.
Vanessa StadlbauerDivision of Gastroenterology and Hepatology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0001-5508-8271
Eva SvehlikovaDivision of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-9743-2031
Martina BrunnerDivision of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.
Nandu GoswamiOtto Loewi Research Centre, Physiology Division, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-6704-0723
Harald KojzarDivision of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.
Peter N PferschyDivision of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.
Thomas R PieberDivision of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-3554-0405
Harald SourijDivision of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-3510-9594
Medical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The EndoBarrier™ medical device is a duodenal-jejunal bypass liner designed to mimic the effects of gastric bypass surgery to induce weight loss and glycaemic improvement. In this study, 10 participants with type 2 diabetes mellitus (T2DM), a mean body mass index (BMI) of 43.3 ± 5.0 (kg/m

Indexed as

Insulin ResistanceProstheses and ImplantsAdiposityAdultBariatric SurgeryBlood GlucoseDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansJejunumMaleMiddle AgedObesityWeight LossBlood GlucoseGlycated HemoglobinBotnia clampduodenal-jejunal bypass linerEndoBarrier™obesitytype 2 diabetes mellitus

Identifiers

PMID33919949
PMCPMC8070956
OpenAlexW3155562427

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.